Lates News

In early trading on Tuesday, the stock price of Johnson & Johnson fell by 0.8% after the company appointed former CEO of Amgen Inc., John Morrissey, to its board. Johnson & Johnson stated that Morrissey has extensive leadership experience and currently serves on the boards of several other companies.